Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
Read Article
News
2024
2023
Archive
Search news articles
March 11, 2024
Skye Bioscience Announces $40 Million Private Placement Equity Financing
March 7, 2024
NodThera’s NLRP3 Inhibitor NT-0796 Reverses Neuroinflammation in Parkinson’s Disease Phase Ib/IIa Trial
February 27, 2024
Skye Bioscience Completes Enrollment of Phase 2a Clinical Trial of SBI-100 Ophthalmic Emulsion in Glaucoma and Ocular Hypertension
February 27, 2024
Dianthus Therapeutics Announces Initiation of Phase II Magic Trial of DNTH103 in Generalized Myasthenia Gravis (GMG)
February 23, 2024
Artiva Biotherapeutics Receives FDA Fast Track Designation for AlloNK® in Lupus Nephritis
February 20, 2024
NodThera Publishes Preclinical Data Demonstrating Reversal of Obesity and Inflammation with Clinical-stage Brain-penetrant NLRP3 Inflammasome Inhibitors
February 14, 2024
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
February 12, 2024
Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO
February 7, 2024
NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer
February 7, 2024
Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
« Previous Page
1
2
3
4
…
118
Next Page »